In 1979, convinced that many useful therapeutic products were abandoned before reaching their full potential, Dr. Rolland-Yves Mauvernay founded the Swiss-based Debiopharm Group. Nearly 30 years later, he is still driven by the discovery of innovative molecules for the treatment of serious medical conditions.

Starting with two people, himself and his secretary, Dr Mauvernay now heads a group of 300 employees with 500 external consultants. Although he projects himself into the future, his convictions remain unchanged, he values family and humility.

Over the years we have learnt to know when to stop. Our failures have enabled us to move forward, to path the way to success. But more importantly it’s the interconnection between our people that has led to our success.

The two words that best describe the strength and energy of Debiopharm are: collective intelligence.